Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3).

BMC Pulm Med · 2020 · PMC7020591 · PMID 32054473

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a trend toward significanceno p-value reported

Secondary analysis of AIRFLOW-2, a phase IIB safety multicenter study using a 1:1 randomized, sham-controlled, double-blinded design showed a statistically significant decrease in hospitalizations for COPD exacerbation with a trend toward significance for moderate-to-severe exacerbations [ 11 ].

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.